Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Electrophilic Fluorination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113402361A introduces a novel hypervalent iodine reagent for direct gem-difluorovinylation, offering streamlined synthesis and cost reduction in pharmaceutical intermediate manufacturing.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.
Novel Selectfluor-mediated method for alpha-acyloxy thioethers. High yield, green chemistry, scalable process for pharmaceutical intermediates manufacturing.
Patent CN102285919A reveals a gold-catalyzed route for 4-fluoro pyrazoles. Mild conditions, high yields, and broad substrate scope ensure cost-effective manufacturing for pharma intermediates.
Novel Selectfluor-mediated method avoids toxic acryloyl chloride. High yield, green process for reliable pharmaceutical intermediate supply.
Patent CN105837539B details mild Selectfluor fluorination for high-purity benzofuran derivatives offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Patent CN114181168A reveals a Selectfluor-mediated C-H activation route for benzothiazinones, offering high purity and simplified manufacturing for pharmaceutical supply chains.